Summary
The non-obese diabetic (NOD) mouse spontaneously develops autoimmune Type 1 (insulin-dependent) diabetes mellitus. NOD mice exhibit massive infiltrates of T cells and macrophages into pancreatic islets (insulitis) prior to diabetes. The contribution of oxygen free radicals to the development of insulitis in NOD mice was examined by administration of its scavengers, such as superoxide dismutase and catalase. Bovine superoxide dismutase and catalase were each coupled to polyethylene glycol. The treatment with superoxide dismutase-polyethylene glycol reduced the number of islets with insulitis and increased the undamaged islet tissue, as compared with the control group. The treatment with catalase-polyethylene glycol showed a similar tendency which did not reach significance. Using a flow cytometric assay of the oxidation of 2′, 7′-dichlorofluorescein, the content of reactive oxygen intermediates in islet cells in the culture system was measured and the effect of peritoneal exudate cells and T cells on their production examined. Peritoneal exudate cells, but not T cells, from NOD mice increased the content of reactive oxygen intermediates in islet cells of either the NOD mouse or the ILI mouse (MHC-identical to NOD); the addition of superoxide dismutase to the culture medium suppressed this increase in NOD or ILI islet cells. The present data support the concept that production of oxygen free radicals mediated by macrophages can damage islet beta cells, directly resulting in autoimmune Type 1 diabetes in NOD mice.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Like AA, Rossini AA (1984) Spontaneous autoimmune diabetes mellitus in the BioBreeding/Worcester rat. Surv Synth Pathol Res 3: 131–138
Makino S, Kunimoto K, Muraoka Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese, diabetic strain of mice. Exp Anim 29: 1–13
Makino S, Harada M, Kishimoto Y, Hayashi Y (1986) Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. Exp Anim 35: 495–498
Fukuda M, Horio F, Kubo R, Hattori M (1989) Monoclonal antibody F23.1 against T-cell bearing Vβ8 TcR elements can prevent the development of insulitis in NOD mice. Diabetes 38 [Suppl 2]: 12A (Abstract)
Miller BJ, Appel MC, O'Neil JJ, Wicker LS (1988) Both the Lyt-2+ and L3T4+ subsets are required for the transfer of diabetes in non-obese diabetic mice. J Immunol 140: 52–58
Acha-Orbea H, Mitchell DJ, Timmermann L, Steinmann L (1988) Limited heterogeneity of T-cell receptors from lymphocytes mediating autoimmune encephalomyelitis allow specific immune intervention. Cell 54: 263–273
Shizuru JA, Taylor-Edwards C, Livingstone A, Fathmann CG (1991) Genetic dissection of T cell receptor Vβ gene requirements for spontaneous murine diabetes. J Exp Med 174: 633–638
McDuffie M (1991) Diabetes in NOD mice does not require T-lymphocytes expressing of Vβ8 or Vβ5. Diabetes 40: 1555–1559
Uchigata Y, Yamamoto H, Kawamura A, Okamoto H (1982) Protection by superoxide dismutase, catalase, and poly (ADP-ribose) synthetase inhibitors against alloxanand streptozotocin-induced islet DNA standard breaks and against the inhibition of proinsulin synthesis. J Biol Chem 257: 6084–6088
Uchigata Y, Yamamoto H, Nagai H, Okamoto H (1983) Effect of poly (ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes 32: 316–318
Wilson GL, Leiter HE (1990) Streptozotocin interactions with pancreatic β cells and the induction of insulin-dependent diabetes. Curr Top Microbiol Immunol 156: 27–54
Wilson GL, LeDoux SP (1993) Interactions of chemicals with pancreatic β-cells. In: Shafrir E (ed); Lessons from animal diabetes; Vol 4. Smith-Gordon, London, pp 17–26
Wilson GL, Hartig PC, Patton NJ, LeDoux SP (1988) Mechanisms of nitrosourea-induced β-cell damage: activation of poly (ADP-ribose) synthetase and cellular distribution. Diabetes 37: 213–216
Wilson GL, Patton NJ, McCord JM, Mullins DW, Mossman BT (1984) Mechanisms of streptozotocin- and alloxan- induced damage in rat B cells. Diabetologia 27: 587–591
Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarai S (1982) Preventive and therapeutic effects of largedose nicotinamide injections on diabetes associated with insulitis: an observation in non-obese diabetic (NOD) mice. Diabetes 31: 749–753
Murray HW, Spitalny GL, Nathan CF (1985) Activation of mouse peritoneal macrophages in vitro and in vivo by interferon. J Immunol 134: 1619–1622
Nomikos IN, Prowse SJ, Carotenute P, Lafferty KJ (1986) Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes 35: 1302–1304
Hattori M, Makino S (1988) Type I (insulin-dependent) diabetes. Exp Med 6: 78–86
Hattori M, Fukuda M, Ichikawa T, Baumgartl H-J, Kato H, Makino S (1990) A single recessive non-MHC diabetogenic gene determines the development of insulitis in the presence of an MHC-linked diabetogenic gene in NOD mice. J Autoimmunity 3: 1–10
McCord JM, Fridovich I (1969) Superoxide dismutase. J Biol Chem 244: 6049–6055
Beers RF, Sizer IW (1952) Aspectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195: 133–140
Bonner-Weir S, Trent DF, Honey RN, Weir GC (1981) Responses of neonatal rat islets to streptozotocin: limited β-cell regeneration and hyperglycemia. Diabetes 30: 64–69
Kubo TR, Born W, Kappler JW, Marrack P, Pigeon M (1989) Characterization of a monoclonal anitbody which detects all murine αβ T-cell receptors. J Immunol 142: 2736–2742
Staertz UD, Rammensee H, Benedetto JD, Bevan MJ (1985) Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol 134: 3994–4000
Leo O, Foo M, Sach DH, Samelson LE, Bluestone JA (1987) Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 84: 1374–1378
Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130: 1910–1917
Grankvist K, Markland S, Taljedal I (1981) Superoxide dismutase is a prophylactic against alloxan diabetes. Nature 294: 158–160
Nomikos IN, Wang Y, Lafferty KJ (1989) Involvement of radicals in autoimmune diabetes. Immunol Cell Biol 67: 85–87
Abuchowski A, McCoy JR, Paiczuk NC, Van Es T, Davis FF (1977) Effect of covalent attachment of polyethylene glycol on immunogenecity and circulating life of bovine liver catalase. J Biol Chem 252: 3582–3586
Hershfield MS, Buckley RH, Greenberg ML et al. (1987) Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med 316: 589–596
Yano N, Ikegami H, Sato T et al. (1988) Orchiectomy increases L3T4 (helper) and Lyt2 (cytotoxic/suppressor) T lymphocytes in the thymus and accelerates B-cell destruction of the non-obese diabetic mouse. Diabetologia 31: 560A (Abstract)
Wicker LS, Miller BJ, Mullen Y (1986) Transfer of autoimmune diabetes mellitus with splenocytes from non-obese diabetes (NOD) mice. Diabetes 35: 855–860
Fukuda M, Horio F, Rittershaus C, Kato H, Hattori M (1990) Macrophages but not T-cells can increase the content of free-radical oxygen in islet β-cells of the NOD mouse. Clin Res 38: 308A (Abstract)
Charlton B, Bacelj A, Mandel TE (1988) Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 37: 930–935
Lee K, Amano K, Yoon J (1988) Evidence for initial involvement of macrophage in the development of insulitis in NOD mice. Diabetes 37: 989–991
Hutchings P, Rosen H, O'Reilly L, Simpson E, Gordon S, Cooke A (1990) Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348: 639–642
Ziegler K, Unanue ER (1981) Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to lymphocytes. J Immunol 127: 1869–1875
Fukuda M, Horio F, Rittershaus C, Kato H, Hattori M (1991) MHC class-II I-A restriction of free-radical oxygen production in islet beta-cells by peritoneal exudate cells of the diabetic NOD mouse. Clin Res 39:246A (Abstract)
Ikegami H, Makino S, Harada M, Eisenbarth GS, Hattori M (1988) The cataract Shionogi mouse, a sister strain of the non-obese diabetic mouse: similar class II but different class I gene products. Diabetologia 31: 254–258
Adams D (1982) Molecules, membranes and macrophage activation. Immunol Today 3: 285–287
Durum SK, Schmidt JA, Oppenheim JJ (1985) Interleukin-1: an immunological perspective. Ann Rev Immunol 3: 263–287
Beutler B, Greenwald D, Hulmes JD et al. (1985) Identity of tumor necrosis factor and macrophage-secreted factor cachectin. Nature 316: 552–554
Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M (1986) Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232: 1545–1547
Palmer JP, Helqvist S, Spinas GA et al. (1989) Interaction of β-cell activity and. IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 28: 1211–1216
Pukel C, Baquerizo H, Rabinovitch A (1988) Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37: 133–136
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horio, F., Fukuda, M., Katoh, H. et al. Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells. Diabetologia 37, 22–31 (1994). https://doi.org/10.1007/BF00428773
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00428773